Seen as an alternative to Ozempic, medicine was approved on Monday for care against obesity
The National Health Surveillance Agency (Anvisa) approved the use of the drug Mounjaro (tirzepatida) for the treatment of obesity. Seen as an alternative to Ozempic (semaglutado), the pen was already marketed in the country with the permission to treat Type 2 diabetes.
Receive the main news directly on WhatsApp! Sign up for the Earth channel
The resolution was published in the edition of this Monday, 9, of the Official Gazette (Dou). According to Andreia Antoniolli, surgeon, researcher and regenerative medicine teacher, can be a great ally in the treatment of conditions, however, it is necessary to be a patient indicated and the administration must be connected to a series of habits. “It can be used, yes, as a good tool for weight loss. Until this is used: as a tool“Explains.
“Because if you don’t do it, make the pen, or Mounjaro or Ozepic, the patient will lose weight, but then when you remove the pen and do not regulate everything, you have not introduced new habits in the life of this patient […] What happens? If he returns to eating wrong, if he continues with hormonal insufficiencies and chronic subclinical inflammation, he will have the weight of the weight, “says the expert expert Earth.
Mounjaro X Ozempic: what are the differences
According to Antoniolli, Mounjaro operates in two amazing receptors. Increase the secretion of insulin and reduces glucagon, which is a hormone linked to fat and slow gastric emptying, investigating gip (gastric inhibitory polypeptide), improving the lpg-1 response (peptide-1 similar to glucagon) that helps to control blood sugar levels.
“In the case of Ozempic, it has only the GLP-1 and has similar but less wide effects. With Tirzepatitada, one improves the effect of the other. Therefore, Mounjaro shows a loss of up to 22% of fats, while Ozempic, which is a maximum of 15%,” he explains.
The two act in obesity by slowing down gastric emptying and therefore hunger. Being the most powerful tirzepatid (Mounjaro). “In addition, when they improve secretion and sensitivity to insulin, they end up helping to treat energy metabolism because when insulin falls, we reduce insulin in the blood, our body has the ability to burn fat and also help to significantly reduce visceral fat,” he says.
Costs
The box with 4 dosage pens 2.5 mg will cost R $ 1,406.75 A R $ 1,907.29Among the prices ranging from electronic commerce to physical stores, with the possibility of discounts through the manufacturer’s program. Already the box with 4 dosage pens 5 mg Can cost R $ 1,759.64 A R $ 2,384.34in the same conditions.
Ozepic varies from $ 963 to $ 999.
Are there any contraindications or side effects?
According to Antonolli, yes. “The adverse effects are very common such as nausea, vomiting, constipation, fatigue and sometimes diarrhea. But much more common in semaglutado (ozempico) than in Tirzepatida (Mounjaro)”, he underlines.
The doctor also underlines that patients who have had pancreatitis, serious digestive problems, advanced kidney diseases, especially without follow -up -Up, should seek the opinion of a professional. “The main opposite is that the person has no indications. They are the people who are not obese and do not have the reason to use the drug and the use has been indiscriminate for half,” he says.
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
